Industry reports
Editor highlights

Human Insulin Research Reports, April 2014

You might be interested in: insulin, biosimilar, therapeutics, more »


 

1-10 of 12 reports for Human Insulin
BIOTON S.A. (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits

BIOTON S.A. (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • February 2014
  • by Global Data

... Company that manufactures and distributes pharmaceutical products with focus on insulin treatment. The company's major products include recombinant human insulin for injections, oral hypoglycemic drugs ...

Bioton S.A. (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton S.A. (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Products with focus on insulin treatment. The company's major products include recombinant human insulin for injections, oral hypoglycemic drugs containing live cultures of bacteria, antibiotics and eye ...

Biomm S.A. (BIOM4) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biomm S.A. (BIOM4) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Of human insulin and other recombinant proteins. Its technology is used in the production of therapeutic proteins such as calcitonin, interferons and growth hormones. Biomm offers processes ...

Adocia (ADOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adocia (ADOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... On the formulation of a fast-acting human insulin and has received adequate phase i/ii results on a diabetic foot ulcer-healing product. Adocia is headquartered in lyon, france. With the positive results ...

Global and China Insulin Industry Report, 2013-2017

Global and China Insulin Industry Report, 2013-2017

  • $ 1 900
  • Industry report
  • December 2013
  • by Research In China

... To technical barriers, china's insulin market is mainly occupied by novo nordisk, sanofi and eli lilly, of which, novo nordisk accounted for 60.3% In 2012. While in recombinant human insulin market segments ...

Global and China Recombinant Human Insulin Industry 2013 Market Research Report

Global and China Recombinant Human Insulin Industry 2013 Market Research Report

  • $ 2 200
  • Industry report
  • September 2013
  • by QY Research Group

... And chinese situation is also offered.Global and china recombinant human insulin industry research report 2013 also focuses on development policies and plans for the industry as well as a consideration ...

Diabetes Treatments: World Drug Market 2013-2023

Diabetes Treatments: World Drug Market 2013-2023

  • $ 2 621
  • Industry report
  • April 2013
  • by Visiongain

... To improve awareness gather pace12. The diabetes drug market: r&d pipeline, 201312.1 Discovering new treatments and molecular targets12.2 human insulins and analogues: pipeline ...

China Insulin Industry Report, 2012-2015

China Insulin Industry Report, 2012-2015

  • $ 1 800
  • Industry report
  • January 2013
  • by Research In China

... Extension project with the investment exceeding usd40 million was also put into service. Jilin-based tonghua dongbao pharmaceutical is china's largest recombinant human insulin producer ...

Chinese Markets for Insulin

Chinese Markets for Insulin

  • $ 4 000
  • Industry report
  • January 2013
  • by Asia Market Information & Development Company

... China's insulin consumption by marketschina's animal insulin production and demandthe output and market share of animal insulin major producers china's human insulin production and demandthe output ...

Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018

Global Diabetes Devices Market And Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share & Forecast 2011 - 2018

  • $ 4 395
  • Industry report
  • December 2012
  • by Transparency Market Research

... Insulinby action short acting pre-mixes long actingby type human insulin modern insulin animal insulinby purchase type dosage bulk ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.